Ignite Creation Date:
2024-05-06 @ 7:48 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02601937
Status:
COMPLETED
Last Update Posted:
2021-12-27
First Post:
2015-10-21
Brief Title:
EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Sponsor:
Epizyme Inc
Organization:
Epizyme Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-21
First Submit QC Date:
November 9 2015
Study First Post Date:
2015-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-27
Last Update Post Date:
2021-12-27
Last Update Post Date Type:
ACTUAL